Pershing Square | Activist Presentation Deck | 120 slides · page 33 of 120
The slide uses a comparative logic to argue against using current market value for the Valeant/Allergan deal.
Activist deck · valuation_table · present_framework · balanced density
Slide locked Sign in to view
Slide schematic 5/5
list 3/3 source-note 1/1 title 1/1
Components 5
bullet bullet bullet source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1